Evidence map›Paper›PMID 32166040›Full record

ArticleJFMS open reports

Nasal adenocarcinoma as a suspected secondary malignant neoplasm in a cat previously treated for nasal lymphoma.

Gabrielle F Callanan, Kaitlin M Curran, Cyril Parachini-Winter, Shay Bracha, Sean Spagnoli, Duncan S Russell, Susanne M Stieger-Vanegas, Lynn Griffin, Haley Leeper

Open access · goldAbstract readCase Reports
In one paragraph

Article in JFMS open reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Gabrielle F CallananDepartment of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.ORCID https://orcid.org/0000-0001-9112-5084
Kaitlin M CurranDepartment of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Cyril Parachini-WinterDepartment of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Shay BrachaDepartment of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Sean SpagnoliDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Duncan S RussellDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Susanne M Stieger-VanegasDepartment of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Lynn GriffinCollege of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Haley LeeperDepartment of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA.
Oregon State University · USColorado State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

case summaryA case of nasal adenocarcinoma as a suspected secondary malignant neoplasm following definitive radiation therapy and multiagent chemotherapy for nasal lymphoma is described. An 11-year-old spayed female domestic shorthair cat was presented for a 3-week history of progressive facial swelling located over the nasal planum and extending to the medial canthus of the right eye. The cat was previously diagnosed with nasal lymphoma and treated with chemotherapy and definitive radiation 2.5 years prior. Although a definitive diagnosis could not be obtained via cytology, recurrent lymphoma was suspected based on the cat's history and recurrent clinical signs. A lymphoma-directed chemotherapy protocol was attempted, but no clinical response was achieved. The cat was euthanased owing to progressive clinical signs and a diagnosis of nasal adenocarcinoma was made on necropsy examination. Both the original diagnosis of nasal lymphoma and the secondary diagnosis of nasal adenocarcinoma were confirmed with immunohistochemistry. RELEVANCE AND NOVEL INFORMATION: Secondary malignant neoplasm following radiation therapy is infrequently reported in the veterinary literature. In the few reports that exist, most have described sarcoma development in the dog following radiation therapy. In the present report, we describe a cat with a suspected radiation-induced nasal adenocarcinoma that developed 2.5 years after definitive radiation treatment for nasal lymphoma.

Indexed as

adenocarcinomachemotherapylymphomaNasalradiotherapysecondary malignant neoplasm

Identifiers

PMID32166040
PMCPMC7052471
OpenAlexW3008797717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.